Published in Nursing Home and Elder Business Week, September 17th, 2006
According to recent research published in the journal Academic Emergency Medicine, investigators aimed "to test novel markers of acute coronary syndrome (ACS), monocyte chemoattractant protein-1(MCP), myeloperoxidase (MPO), C-reactive protein (CRP), and brain natriuretic peptide (BNP) in low-risk emergency department (ED) patients who were evaluated for ACS in a chest pain unit (CPU)."
"A convenience sample of 414 patients underwent CPU evaluation, including provocative testing, and were followed prospectively for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Nursing Home and Elder Business Week